Jennifer Champoux

Patrimonio netto: 809 999 $ in data 31/05/2024

Health Technology

Consumer Services

Posizioni attive di Jennifer Champoux

Società	Posizione	Inizio	Fine
MONTE ROSA THERAPEUTICS, INC.	Direttore operativo	01/03/2021	-
MONTE ROSA THERAPEUTICS, INC.	Ufficiale delle Risorse Umane	01/03/2021	28/05/2024

Società	Posizione	Inizio	Fine
H3 Biomedicine, Inc. H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa.	Corporate Officer/Principal	-	-

Indiana University

Graduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Chief Operating Officer	1
Human Resources Officer	1
Corporate Officer/Principal	1

Settori

Health Technology	3
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
MONTE ROSA THERAPEUTICS, INC.	Health Technology

Aziende private	1
H3 Biomedicine, Inc. H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa.	Health Technology

Aziende private

Health Technology